India to Congo The Democratic Republic Of The Pharmaceutical Export (2026) — $14.1M, 95 Suppliers | TransData Nexus

India to Congo The Democratic Republic Of The Pharmaceutical Export (2026) — $14.1M, 95 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Congo The Democratic Republic Of The

#	Formulation	Value	Share
1	Dtp Hepb Hib Pentavalent Vaccine Fullyliquid Combination Vaccine 10 Dose Vialpa…	$1.5M	10.5%
2	Dtp-hepb-hib (pentavalent Vaccine)fullyliquid Combination Vaccine 10 Dose (5ml)…	$752.4K	5.3%
3	Ethambutol Hydrochloride Dispersible Tablets 100mg Pack28160	$564.6K	4.0%
4	Diphtheria & Tetanus Vaccine (adult)10 Dose with Vvm Vaccine for Human Medvls	$210.0K	1.5%
5	Material No 44103144 Mb Adult 360kitv1 Int Mfg Licence No Kd 390	$168.8K	1.2%
6	Diptheria and Tetanus Dt Tetanus Anddiphtheria Td Adsorbed for Adults Andadoles…	$167.1K	1.2%
7	Zebu Paracetamol BP 325 MG Diclofenac Sodium BP 50 MG Caffeine Anhy BP 30 MG Ta…	$153.7K	1.1%
8	Harmless Medicine for Human Consumption(funbact A) Other Details As Per Invoice…	$136.2K	1.0%
9	Harmless Pharmaceutical Medicines Finished Formulation Cefixime Dispersible 200…	$120.1K	0.9%
10	Artesunate for Injection 180 MG Start 180 As Per Inv	$114.5K	0.8%
11	Ketazol Cream 15g E/f/p (s/r)	$112.8K	0.8%
12	Dolutegravir Sodium 10mg Tablet for Oral Suspension (dispersible Tablets) - Dru…	$107.6K	0.8%
13	Tramadol Hydrochloride Injection (dozem)( Ml)	$102.9K	0.7%
14	Cypro 500 Tablets Each Film Coated Tablets Contains Ciprofloxacin Hcl USP Eq to…	$93.9K	0.7%
15	Non Harmfull Pharmaceutical Products for Human Consumption Ibuprofene 400tablet…	$88.0K	0.6%

India exports 20+ pharmaceutical formulations to Congo The Democratic Republic Of The with a combined trade value of $14.1M. Key products include Ethambutol ($565K), Paracetamol ($154K), Artesunate ($115K), Dolutegravir ($108K), Tramadol ($103K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,952 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Congo The Democratic Republic Of The Trade Routes

1Ethambutol$565K

2Paracetamol$154K

3Artesunate$115K

4Dolutegravir$108K

5Tramadol$103K

Top Indian Exporters to Congo The Democratic Republic Of The

1Shalina Laboratories Private Limited

$2.1M

2Biological E Limited

$1.6M

3Biomatrix Healthcare Private Limited

$1.3M

4Aura Pharmaceuticals Private Limited

$1.1M

Port Analysis — India to Congo The Democratic Republic Of The Pharmaceutical Shipments

Indian Export Ports

JNPT57.1%

Hyderabad Air Cargo0.2%

AHEMDABAD ICD6.0%

HYDERABAD AIR0.1%

SAHAR AIR15.9%

Congo The Democratic Republic Of The Import Ports

MATADI31.7%

Matadi22.5%

KINSHASA25.6%

DAR ES SALAAM10.6%

Kinshasa2.2%

Trade Statistics

Total Value$14.1M

Shipments1,952

Indian Exporters95

Congo The Democratic Republic Of The Buyers80

Avg Shipment$7K

Products1,375

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Congo The Democratic Republic Of The Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and the Democratic Republic of the Congo (DRC) has experienced significant growth over the past decade. In 2024, India exported pharmaceutical products worth $149.98 million to the DRC, marking a substantial increase from previous years. This upward trajectory underscores the strengthening trade relations and India's growing role as a key supplier of pharmaceutical products to the DRC.

The trade is characterized by a diverse range of products, with vaccines and essential medicines being prominent among the exports. The DRC's reliance on imported pharmaceuticals, due to limited domestic manufacturing capabilities, has further bolstered India's export volumes. This trend reflects India's strategic positioning in the global pharmaceutical market and its capacity to meet the DRC's healthcare needs.

2India's Market Position

India holds a significant share in the DRC's pharmaceutical import market, positioning itself as a primary supplier alongside other countries like China and regional partners. In 2024, India's pharmaceutical exports to the DRC were valued at $149.98 million, contributing to a total of $543.72 million in exports from India to the DRC. This substantial share highlights India's strategic importance in the DRC's pharmaceutical supply chain.

The DRC's dependence on imported pharmaceuticals, with local manufacturing accounting for only about 10% of the total market, underscores India's pivotal role in meeting the country's healthcare demands. India's competitive pricing, adherence to international quality standards, and a broad portfolio of products enhance its appeal to Congolese importers.

Congo The Democratic Republic Of The Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export to the DRC must navigate a structured registration process to ensure compliance with local regulations. The DRC requires that pharmaceutical products be registered with the Ministry of Health and carry instructions in French. This necessitates the submission of comprehensive product dossiers, including details on composition, manufacturing processes, and clinical data.

The registration process is managed by the Autorité Congolaise de Réglementation Pharmaceutique (ACOREP), which oversees the authorization and control of drug imports and exports. While the DRC's regulatory framework is evolving, adherence to the World Health Organization's Good Manufacturing Practices (WHO-GMP) is essential for product approval. The timeline for registration can vary, but it is advisable for exporters to anticipate a thorough evaluation period.

2GMP & Facility Requirements

The DRC mandates that pharmaceutical products imported into the country comply with Good Manufacturing Practices (GMP) standards. This ensures that products are consistently produced and controlled according to quality standards. Indian manufacturing facilities must adhere to WHO-GMP guidelines to meet these requirements.

The inspection process involves ACOREP evaluating the manufacturing facilities to verify compliance with GMP standards. While mutual recognition agreements may exist, it is crucial for Indian exporters to stay updated on any changes in the DRC's regulatory policies. Ensuring GMP compliance not only facilitates smoother market entry but also enhances the credibility and acceptance of Indian pharmaceutical products in the DRC.

3Import Documentation

Importing pharmaceutical products into the DRC requires meticulous documentation to ensure compliance with local regulations. Key documents include the Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and proof of GMP compliance. These documents substantiate the product's quality and safety standards.

The import process also involves customs procedures, where the General Directorate of Customs and Excises (DGDA) assesses and collects applicable duties and taxes. Pharmaceutical imports may benefit from preferential duty rates, such as a 2% ad valorem tax on the Cost, Insurance, and Freight (CIF) value. Ensuring all documentation is accurate and complete is vital to prevent delays and facilitate a smooth import process.

TransData Nexus Research · Congo The Democratic Republic Of The regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Congo The Democratic Republic Of The

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

India's pharmaceutical exports to the DRC are predominantly composed of vaccines and essential medicines, aligning with the DRC's healthcare needs. Products like the DTP HEPB HIB Pentavalent Vaccine and various forms of DTP vaccines are among the top exports, reflecting the DRC's focus on immunization programs. Additionally, treatments for tuberculosis, such as Ethambutol Hydrochloride Dispersible Tablets, are significant, addressing the country's disease burden.

The dominance of these categories is driven by the DRC's high incidence of infectious diseases and the need for preventive and therapeutic interventions. Indian pharmaceutical companies' ability to provide these essential products at competitive prices enhances their appeal in the Congolese market.

2Emerging Opportunities

The DRC's evolving healthcare landscape presents emerging opportunities for Indian pharmaceutical exporters. With the global shift towards biosimilars and the DRC's increasing focus on affordable healthcare solutions, there is potential for Indian companies to introduce biosimilar products to meet local demand. Additionally, the DRC's efforts to strengthen its healthcare infrastructure may open avenues for exporting medical equipment and diagnostic tools.

Staying attuned to these developments and aligning product offerings with the DRC's healthcare priorities can position Indian exporters favorably in the market.

3Demand Drivers

The DRC's substantial disease burden, including high rates of infectious diseases like malaria, tuberculosis, and HIV/AIDS, drives the demand for pharmaceutical imports. The country's limited domestic manufacturing capacity, with local production accounting for only about 10% of the market, further amplifies this reliance on imports.

Additionally, the DRC's growing population and urbanization trends contribute to increased healthcare needs, thereby boosting pharmaceutical demand. The government's initiatives to improve healthcare access and infrastructure also play a role in elevating the demand for imported pharmaceutical products.

TransData Nexus Research · DGFT trade data analysisMar 2026

Trade Policy & Tariff Intelligence — India and Congo The Democratic Republic Of The

Tariff structure, trade agreements, IP and patent landscape

1Tariff & Duty Structure

The DRC's import duty structure is designed to regulate the inflow of goods and generate fiscal revenue. Pharmaceutical products are subject to an ad valorem duty, calculated as a percentage of the Cost, Insurance, and Freight (CIF) value. The standard duty rates are 5%, 10%, and 20%, depending on the product category. However, pharmaceutical imports benefit from a preferential duty rate of 2% on the CIF value.

In addition to import duties, a Value Added Tax (VAT) of 16% is levied on most imports, calculated on the total CIF value plus the applicable customs duty. Specific consumption taxes may also apply to certain luxury goods, with rates potentially reaching up to 60%. Understanding this tariff and duty structure is crucial for Indian exporters to accurately assess costs and pricing strategies.

2Trade Agreements

The DRC is a member of the World Trade Organization (WTO) and has engaged in various trade agreements that influence its import policies. While specific free trade agreements (FTAs) with India are not prominently documented, the DRC's participation in regional trade agreements may impact pharmaceutical trade dynamics. It's essential for Indian exporters to stay informed about any bilateral or multilateral agreements that could affect trade terms and conditions.

3IP & Patent Landscape

The DRC's intellectual property (IP) framework, including patent provisions and data exclusivity, plays a role in the pharmaceutical sector. While specific details on IP regulations are limited, it's important for Indian exporters to ensure that their products do not infringe on existing patents in the DRC. Additionally, understanding the DRC's stance on compulsory licensing is vital, as it can influence market entry strategies and the protection of proprietary formulations.

TransData Nexus Research · Trade policy databasesMar 2026

FAQ — India to Congo The Democratic Republic Of The Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Congo The Democratic Republic Of The?

India exported pharmaceuticals worth $14.1M to Congo The Democratic Republic Of The across 1,952 verified shipments.

Who are the top Indian pharmaceutical exporters to Congo The Democratic Republic Of The?

1. SHALINA LABORATORIES PRIVATE LIMITED — $2.1M. 2. BIOLOGICAL E LIMITED — $1.6M. 3. BIOMATRIX HEALTHCARE PRIVATE LIMITED — $1.3M. Total: 95 suppliers.

Which companies in Congo The Democratic Republic Of The import pharmaceuticals from India?

1. SHALINA HEALTHCARE SARL — $2.1M. 2. UNIQUE PHARMA — $1.9M. 3. PEV LMTE MINISTERE DE LA SANTE — $1.5M. 80 buyers total.

What pharmaceutical products does India export most to Congo The Democratic Republic Of The?

1. Dtp Hepb Hib Pentavalent Vaccine Fullyliquid Combination Vaccine 10 Dose Vialpa… ($1.5M, 10.5%); 2. Dtp-hepb-hib (pentavalent Vaccine)fullyliquid Combination Vaccine 10 Dose (5ml)… ($752.4K, 5.3%); 3. Ethambutol Hydrochloride Dispersible Tablets 100mg Pack28160 ($564.6K, 4.0%); 4. Diphtheria & Tetanus Vaccine (adult)10 Dose with Vvm Vaccine for Human Medvls ($210.0K, 1.5%); 5. Material No 44103144 Mb Adult 360kitv1 Int Mfg Licence No Kd 390 ($168.8K, 1.2%)

Which ports handle pharmaceutical shipments from India to Congo The Democratic Republic Of The?

Export: JNPT, Hyderabad Air Cargo, AHEMDABAD ICD, HYDERABAD AIR, SAHAR AIR. Import: MATADI, Matadi, KINSHASA, DAR ES SALAAM, Kinshasa.

Why does Congo The Democratic Republic Of The import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $14.1M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Congo The Democratic Republic Of The?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Congo The Democratic Republic Of The pharmaceutical trade?

$7.2K per consignment across 1,952 shipments.

How many Indian pharmaceutical companies export to Congo The Democratic Republic Of The?

95 Indian companies. Largest: SHALINA LABORATORIES PRIVATE LIMITED with $2.1M.

How can I find verified Indian pharmaceutical suppliers for Congo The Democratic Republic Of The?

TransData Nexus covers 95 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Congo The Democratic Republic Of The identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,952 verified shipments from 95 Indian exporters to 80 Congo The Democratic Republic Of The buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

95 Exporters

80 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Congo The Democratic Republic Of The Pharmaceutical Export